Skip to main content

Table 1 Distribution of tumor entities for all benign, malignant and non-neoplastic soft tissue masses ≤5 cm, ≤3 cm and ≤2 cm included in this study

From: Soft tissue masses: distribution of entities and rate of malignancy in small lesions

Benign Malignant Non-neoplastic
Entity ≤5 cm ≤3 cm ≤2 cm Entity ≤5 cm ≤3 cm ≤2 cm Entity ≤5 cm < 3 cm ≤2 cm
Overall 562 (64.6%) 330 (69.77%) 159 (66.25%)   195 (22.41%) 78 (16.49%) 36 (15.0%)   113 (12.99%) 65 (13.74%) 45 (18.75%)
Deep benign fibrous histiocytoma 1 (0.11%) Alveolar soft part sarcoma 4 (0.46%) Bursitis 6 (0.69%) 4 (0.85%) 3 (1.26%)
Fibroma 33 (3.79%) 26 (5.5%) 16 (6.67%) Angiosarcoma of soft tissue 6 (0.69%) 2 (0.43%) Ganglion 65 (7.47%) 42 (8.88%) 27 (11.3%)
Fibromatosis 40 (4.6%) 25 (5.5%) 14 (5.83%) Chondrosarcoma 2 (0.23%) 1 (0.21%) Haematoma 5 (0.57%) 1 (0.21%) 1 (0.42%)
Glomus tumors 1 (0.11%) Clear cell sarcoma of soft tissue 3 (0.34%) 1 (0.21%) 1 (0.42%) Lipoma arborescens 2 (0.23%)
Haemangioma 74 (8.51%) 48 (10.15%) 20 (8.33%) Dermatofibrosarcoma protuberans 7 (0.8%) 5 (1.06%) 3 (1.25%) Pseudotumor 12 (1.38%) 5 (1.06%) 3 (1.26%)
Hamartoma 1 (0.11%) 1 (0.21%) 1 (0.42%) Epithelioid sarcoma 4 (0.46%) 3 (0.63%) 1 (0.42%) Others 23 (2.64%) 13 (2.75%) 11 (4.6%)
Hibernoma 1 (0.11%) . Ewing-Sarcoma 2 (0.23%) 1 (0.21%) 1 (0.42%)     
Lipoma 97 (11.15%) 34 (7.19%) 12 (5.0%) Extraskeletal osteosarcoma 1 (0.11%)     
Lymphangioma 1 (0.11%) Extrapleural solitary fibrous tumour 6 (0.69%) 1 (0.21%) 1 (0.42%)     
Myopericytoma 3 (0.34%) 2 (0.42%) 2 (0.83%) Fibrosarcoma 5 (0.57%) 5 (1.06%) 2 (0.83%)     
Myositis ossificans 2 (0.23%) 2 (0.42%) Haemangioendothelioma 1 (0.11%) 1 (0.21%) 1 (0.42%)     
Myxoma 21 (2.41%) 7 (1.48%) 3 (1.25%) Leyomyosarcoma 18 (2.07%) 10 (2.11%) 6 (2.5%)     
Nodular fasciitis 25 (2.87%) 19 (4.02%) 13 (5.42%) Liposarcoma a 27 (3.1%) 6 (1.27%) 3 (1.25%)     
Perineurioma 1 (0.11%) Lymphoma 7 (0.8%) 1 (0.21%)     
Schwannoma 92 (10.57%) 63 (13.32%) 27 (11.25%) Metastasis 6 (0.69%) 2 (0.42%) 1 (0.42%)     
Tenosynovial giant cell tumor 169 (19.43%) 102 (21.56%) 51 (21.25%) Malignant peripheral nerve sheath tumor 1 (0.11%)     
     Myofibroblastic tumor 6 (0.69%) 5 (1.06%) 1 (0.42%)     
     Myxofibrosarcoma 24 (2.76%) 7 (1.48%) 5 (2.08%)     
     Rhabdomyosarcoma 4 (0.46%) 1 (0.21%)     
     Synovial sarcoma 20 (2.3%) 9 (1.9%) 3 (1.25%)     
     Undifferentiated pleomorphic sarcoma 34 (3.91%) 12 (2.54%) 5 (2.08%)     
     Sarcoma, not otherwise specified 7 (0.8%) 5 (1.06%) 2 (0.83%)     
  1. aof those classified as low-grade liposarcoma/atypical lipomatous tumor: 13 ≤ 5 cm (1.49%), 2 ≤ 3 cm (0.42%), 2 ≤ 2 cm (0.83%)